Abstract
We report a case of therapy-related acute myeloid leukemia (t-AML), which developed following chemotherapy involving cisplatin and 5-fluorouracil for esophageal carcinoma. A 70-year-old man with past history of esophageal carcinoma, which was treated with subtotal esophagectomy 32 months earlier followed by 2 courses of chemotherapy involving cisplatin and 5-fluorouracil, was diagnosed with t-AML. His leukemia was resistant to chemotherapy, and the patient died from pneumonia 4 months after being diagnosed with leukemia. Although treatment for esophageal carcinoma is associated with a markedly lower frequency of therapy-related myeloid neoplasms than treatment for certain other malignancies such as hematological neoplasms, it is important to be aware that therapy-related myeloid neoplasms can occur as late complications of esophageal carcinoma treatment.
Similar content being viewed by others
References
Vardiman JW, Arber DA, Brunning RD, et al. Therapy-related myeloid neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 127–9.
Mauritzson N, Albin M, Rylander L, et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001. Leukemia. 2002;16:2366–78.
Leone G, Fianchi L, Voso MT. Therapy-related myeloid neoplasms. Curr Opin Oncol. 2011;23:672–80.
Leone G, Mele L, Pulsoni A, Equitani F, Pagano L. The incidence of secondary leukemias. Haematologica. 1999;84:937–45.
Smith SM, Le Beau MM, Huo D, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 2003;102:43–52.
Fukunishi K, Kurokawa T, Takeshita A, et al. Acute myelocytic leukemia and plasmacytoma secondary to chemotherapy and radiotherapy in a long-term survivor of small cell lung cancer. Nihon Kokyuki Gakkai Zasshi. 1999;37:415–9.
Otsuka Y, Konishi T, Nara S, Furushima K, Nakajima K, Shimada H. Secondary myelodysplastic syndrome after small cell lung cancer and esophageal cancer. J Gastroenterol Hepatol. 2005;20:1318–21.
Natori K, Izumi H, Ishihara S, et al. Six cases of therapy-related leukemia or myelodysplastic syndrome after treatment for solid cancer. Jpn J Chemother. 2007;55:225–9.
Yamamoto K, Wakahashi K, Okamura A, Katayama Y, Shimoyama M, Matsui T. Two further cases of myelodysplastic syndrome and acute myeloid leukemia with der(5;19)(p10;q10): association with abnormalities involving chromosomes 12 and 21. Leuk Res. 2010;34:e34–41.
Chang H, Liaw CC, Chang HK. Therapy-related acute myeloid leukemia after concurrent chemoradiotherapy for esophageal cancer: report of two cases. Tumori. 2009;95:371–3.
Mimura N, Tsujimura H, Ise M, et al. Therapy-related leukemia following chemoradiotherapy for esophageal cancer. Eur J Haematol. 2010;85:353–7.
Still H, Olipitz W, Zebisch A, Schulz E, Wölfler A. Therapy-related myeloid neoplasms: pathobiology and clinical characteristics. Br J Pharmacol. 2011;162:792–805.
Kaplan HG, Malmgren JA, Atwood MK. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990–2005. BMC Cancer. 2011;11:260.
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manabe, M., Kosaka, K., Nakano, H. et al. Therapy-related acute myeloid leukemia following postoperative adjuvant chemotherapy including cisplatin and fluorouracil for esophageal carcinoma. Esophagus 10, 174–178 (2013). https://doi.org/10.1007/s10388-013-0366-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-013-0366-8